Cecilia H. Kieu

FDA investigator

Appears on 13 documents from 2021 to 2026, mostly at sites in California. Most often cites control of microbiological contamination (21 CFR 211.113).

13
Documents on file
4.7
Observations per 483
2021
First seen
2026
Most recent

What they cite most

From 61 observations

Activity by year

2021: 1, 2022: 1, 2023: 3, 2024: 2, 2025: 3, 2026: 3

Where

California 8 · Arizona 2 · New Mexico 1 · Oregon 1 · Washington 1

Is Cecilia H. Kieu coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 Jubilant HollisterStier LLCJun 17, 2026 · Spokane, Washington
483 VA San Diego Healthcare SystemsMay 8, 2026 · San Diego, California
Amended 483 Pyramid Laboratories, IncFeb 13, 2026 · Costa Mesa, California
483 Tailstorm Health Inc dba Medivant HealthNov 14, 2025 · Phoenix, Arizona
483 Sparsha Pharma Usa IncSep 4, 2025 · Oceanside, California
483 CA-BOTANA INTERNATIONALApr 4, 2025 · SAN DIEGO, California
483 Dental Alliance Holdings LLCOct 24, 2024 · Albany, Oregon

About this profile

What does Cecilia H. Kieu inspect?

Cecilia H. Kieu appears on 13 documents on file covering 13 sites, mostly in California.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.22 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Cecilia H. Kieu is dated Jun 17, 2026.